Recent advancements in the treatment of epithelial ovarian cancer.
Important advances in the management of advanced epithelial ovarian cancer have been made in recent years, with much of the knowledge emanating from clinical trials conducted by the Gynecological Oncology Group (GOG). This monograph reviews the trials that have defined current clinical practice and summarizes some innovative techniques and promising new drugs for the future
DiSaia
P J
PJ
The Division of Gynecologic Oncology, The Chao Family NCI-Designated Comprehensive Cancer Center, University of California, Irvine--Medical Center, Orange 92868, USA.
Tewari
K S
KS
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D006801:Humans; D009364:Neoplasm Recurrence, Local; D010051:Ovarian Neoplasms / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D016032:Randomized Controlled Trials as Topic
D000970:Antineoplastic Agents